Aliment Pharmacol Ther
- AKIYAMA S, Yokoyama K, Yagi S, Shinzaki S, et al
Efficacy and safety of filgotinib for ulcerative colitis: A real-world
multicenter retrospective study in Japan.
Aliment Pharmacol Ther. 2024 Mar 17. doi: 10.1111/apt.17961.
Am J Gastroenterol
- ALLEGRETTI JR, Axelrad J, Dalal RS, Kelly CR, et al
Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab
for Inflammatory Bowel Disease and Recurrent C . difficile Infection.
Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002770.
BMC Gastroenterol
- HU N, Liu J, Gao X, Tang H, et al
Correction: The association between hemoglobin level and sarcopenia in Chinese
patients with Crohn's disease.
BMC Gastroenterol. 2024;24:115.
Clin Exp Immunol
- DUARTE-SILVA M, Parra RS, Feitosa MR, Nardini V, et al
Leukocyte Dysfunction and reduced CTLA-4 Expression are Associated with Perianal
Crohn's Disease.
Clin Exp Immunol. 2024 Mar 22:uxae027. doi: 10.1093.
Clin Gastroenterol Hepatol
- COLOMBEL JF, Hisamatsu T, Atreya R, Bresso F, et al
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction
Therapy.
Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00254.
- PEYRIN-BIROULET L, Panaccione R, Louis E, Atreya R, et al
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease
Regardless of Prior Biologic Exposure.
Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00253.
- PRENTICE R, Flanagan E, Wright EK, Gibson PR, et al
Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel
disease and infants exposed in-utero.
Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00252.
- BAGER P, Hvas CL, Dahlerup JF
Severe Fatigue in Inflammatory Bowel Disease: Dopaminergic Therapy with
Modanfinil or Vitamin Therapy with Thiamine.
Clin Gastroenterol Hepatol. 2024 Mar 18:S1542-3565(24)00283.
Clin Res Hepatol Gastroenterol
- YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A
systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2024;48:102317.
Dig Dis Sci
- PEYRIN-BIROULET L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab
for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel
Disease: A Systematic Literature Review and Network Meta-analysis.
Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-023-08252.
- DEBOLT CA, Gottlieb ZS, Rao MG, Johnson S, et al
Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with
Inflammatory Bowel Disease.
Dig Dis Sci. 2024 Mar 16. doi: 10.1007/s10620-024-08364.
Gastroenterology
- KHROM M, Long M, Dube S, Robbins L, et al
Comprehensive association analyses of extraintestinal manifestations in
inflammatory bowel disease.
Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
Inflamm Bowel Dis
- JAIRATH V, Hunter Gibble T, Potts Bleakman A, Chatterton K, et al
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in
Ulcerative Colitis and Crohn's Disease.
Inflamm Bowel Dis. 2024 Mar 21:izae044. doi: 10.1093.
- FIORINO G, Bent-Ennakhil N, Varriale P, Braegger F, et al
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease:
Results From a Large Survey Across Seven European Countries Using a Discrete
Choice Experiment.
Inflamm Bowel Dis. 2024 Mar 20:izae015. doi: 10.1093.
- JOLVING LR, Zegers FD, Lund K, Wod M, et al
Children and Adolescents Diagnosed With Inflammatory Bowel Disease Are at
Increased Risk of Developing Diseases With a Possible Autoimmune Pathogenesis.
Inflamm Bowel Dis. 2024 Mar 20:izae047. doi: 10.1093.
J Crohns Colitis
-
Corrigendum to: Influence of Early Life Factors, including breast milk
Composition, on the Microbiome of Infants Born to Mothers with and without
Inflammatory Bowel Disease.
J Crohns Colitis. 2024 Mar 20:jjae021. doi: 10.1093.
- VAN GENNEP S, Fung ICN, de Jong DC, Ramkisoen RK, et al
Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients
Treated With Tofacitinib.
J Crohns Colitis. 2024 Mar 20:jjae031. doi: 10.1093.
- CON D, Hilley P, Chin S, Corte C, et al
Safety and effectiveness of Janus kinase inhibitors in the management of
inflammatory bowel disease following liver transplantation.
J Crohns Colitis. 2024 Mar 19:jjae039. doi: 10.1093.
- FUNG M, Farbod Y, Kankouni H, Singh S, et al
Does combined medical and surgical treatment improve perianal fistula outcomes in
patients with Crohn's disease? A systematic review and meta-analysis.
J Crohns Colitis. 2024 Mar 16:jjae035. doi: 10.1093.
J Gastroenterol
- HIRAYAMA D, Hyodo S, Morita K, Nakase H, et al
Change in systemic steroid use and surgery rate in patients with inflammatory
bowel disease: a Japanese real-world database analysis.
J Gastroenterol. 2024 Mar 16. doi: 10.1007/s00535-024-02086.
J Immunol
- CHENG MI, Hong L, Bustillos C, Chen B, et al
Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits
Colitogenic CD4+ T Cells in Mucosal Inflammation.
J Immunol. 2024;212:1069-1074.
PLoS One
- CHEN K, Zhang S, Cui G, Zhang X, et al
Establishment of a hybrid model of atherosclerosis and acute colitis in ApoE-/-
mice.
PLoS One. 2024;19:e0289820.
- SALDOVA R, Thomsson KA, Wilkinson H, Chatterjee M, et al
Characterization of intestinal O-glycome in reactive oxygen species deficiency.
PLoS One. 2024;19:e0297292.
Scand J Gastroenterol
- RADFORD SJ, Abdul-Aema B, Tench C, Leighton P, et al
Substantial cost savings of ultrasound-based management over magnetic resonance
imaging-based management in an inflammatory bowel disease service.
Scand J Gastroenterol. 2024 Mar 19:1-7. doi: 10.1080/00365521.2024.2330588.
- KIASAT A, Prast-Nielsen S, Rautiainen S, Engstrand L, et al
Plasma bile acids in association with Crohn's disease.
Scand J Gastroenterol. 2024 Mar 20:1-9. doi: 10.1080/00365521.2024.2328592.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016